- Home
- PNTG vs VIR Comparison
PNTG vs VIR Comparison
Compare PNTG & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PNTG | VIR |
|---|---|---|
| Founded | 2019 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2019 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PNTG | VIR |
|---|---|---|
| Price | $38.28 | $11.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $37.00 | $19.43 |
| AVG Volume (30 Days) | 250.3K | ★ 1.5M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | 17.49 |
| EPS | ★ 0.49 | N/A |
| Revenue | ★ $947,705,000.00 | $68,556,000.00 |
| Revenue This Year | $24.72 | $270.22 |
| Revenue Next Year | $7.61 | N/A |
| P/E Ratio | $78.06 | ★ N/A |
| Revenue Growth | ★ 36.31 | N/A |
| 52 Week Low | $22.26 | $4.75 |
| 52 Week High | $42.69 | $11.66 |
Technical Indicators
Market Signals| Indicator | PNTG | VIR |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 62.83 |
| Support Level | $37.95 | $8.43 |
| Resistance Level | $42.62 | $10.58 |
| Average True Range (ATR) | 1.12 | 0.45 |
| MACD | -0.16 | 0.17 |
| Stochastic Oscillator | 19.89 | 63.52 |
Price Performance
Historical ComparisonAbout PNTG The Pennant Group Inc.
Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States. It operates in multiple lines of business including home health, hospice, and senior living which includes the company's assisted living, independent living, and memory care communities across Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. It operates in two segments; home health and hospice services and senior living services. The company generates majority of its revenue from home health and hospice services segment, which includes its home health, hospice and home care businesses.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is a clinical-stage biopharmaceutical company focused on powering the immune system by discovering and developing medicines for serious infectious diseases and cancer. The company uses its capabilities in antibody discovery and engineering, coupled with its proprietary AI engine dAIsY system, and the PRO-XTEN masking platform, to quickly and effectively discover and optimize potential new medicines. Its clinical development pipeline consists of investigational therapies like Tobevibart + elebsiran targeting the hepatitis delta virus (HDV), preclinical antibody candidates targeting HIV, and VIR-5500, VIR-5818, VIR-5525, and 7 PRO-XTEN programs targeting multiple solid tumors. Currently, the company generates revenue mainly by issuing license rights and through grants.